Vicineum

Sesen slams brakes on phase 3 bladder cancer program to save cash as it looks for off-ramp
Fierce Biotech
Mon, 07/18/22 - 07:15 pm
Sesen Bio
bladder cancer
clinical trials
Vicineum
Sesen’s corporate spin amounts to nothing
EP Vantage
Mon, 08/16/21 - 11:06 am
Sesen Bio
FDA
Vicineum
FDA rejects Sesen Bio's bladder cancer pitch, sending shares spiraling back to penny stock territory
Endpoints
Sun, 08/15/21 - 11:01 pm
Sesen Bio
FDA
Vicineum
bladder cancer